Work

CCL18 Is an IL-6 Responsive Biomarker in Systemic Sclerosis Associated Interstitial Lung Disease--Analysis from Phase 3 Trial of Tocilizumab

Year: 2020

Type: conference-abstract

DOI: 10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3073

Authors: T. Ramalingam, M. Neighbors, C. Schiffman, X. Gao, X.R. Sheng, J. Jiang, C.J.F. Lin, D. Khanna

Institutions: Genentech, University of Michigan

Language: English

Topic: Systemic Sclerosis and Related Diseases

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3041104931

Cites:

Cited by:

Related to: 10